Abstract
We enrolled 17 healthy adult volunteers and measured platelet hemostasis time (PHT) and collagen-induced thrombus formation (CITF) before and after the oral administration of 300 mg of clopidogrel utilizing the Xylum Clot Signature Analyzer®. We documented a statistically significant 30% prolongation of the PHT from 291 - 13 (SE) seconds to 376 - 31 (SE) s ( P =0.037). There was a 7% prolongation of the CITF from 347 - 10 to 371 - 17 (SE) s ( P =0.245). This study suggests that the Xylum Clot Signature Analyzer can measure changes in platelet function in response to a modest platelet inhibitor, and may be a useful clinical tool for the monitoring of antiplatelet therapies in patients.